NEW YORK (TheStreet) -- I have been talking about, writing about and, most important, investing in stocks for my clients and myself for a long time. You do not have to be a scientist or doctor to invest in scientific or medical progress.
Of the nearly 3,800 stocks I cover in my database, most do not get white-hot overnight. Neither do they lose all their value overnight.
So I look for industries first, then companies within those industries when I am selecting investments. I use the database that I created to select the Best Stocks Now.
That is how I found Anacor Pharmaceuticals
(ANAC - Get Report).
Data from Best Stocks Now App
I didn't hear about ANAC from a televised talking head. Nor did I read about it in the Wall Street Journal
. I found it while scouring the database that I created.
ANAC is in the atopic dermatitis business. Eczema. One of its products is getting some good results and some even say it could be a new standard of treatment for this disease. But just because something is a good company in a good industry with a good even great product, it does not necessarily mean it is a good stock.
ANAC became public in 2010 at $5 per share. I noticed it three months ago when it hit #23 based on my proprietary grading system. Looking at the chart, we see it has done a powerful saucer pattern from April until Mid-August of this year when ANAC broke out and rose up the ranks in my database.
Check Out Our Best Services for Investors
Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts